Uniphar plc (ISE:UPR)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Uniphar Medtech	292.83M	267.97M	249.22M	233.20M	-
Uniphar Medtech Growth	9.28%	7.52%	6.87%	-	-
Uniphar Supply Chain & Retail	2.09B	1.84B	1.71B	1.56B	1.49B
Uniphar Supply Chain & Retail Growth	13.42%	7.71%	9.93%	4.77%	8.75%
Uniphar Pharma	690.77M	658.81M	592.23M	280.43M	-
Uniphar Pharma Growth	4.85%	11.24%	111.18%	-	-
Commercial & Clinical	-	-	-	-	299.91M
Commercial & Clinical Growth	-	-	-	-	11.17%
Product Access	-	-	-	-	157.15M
Product Access Growth	-	-	-	-	-16.19%
Total	3.07B	2.77B	2.55B	2.07B	1.94B
Total Growth	10.98%	8.51%	23.30%	6.56%	6.54%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Ireland	2.37B	2.11B	1.95B	1.77B	1.67B
Ireland Growth	12.52%	8.00%	10.63%	5.56%	8.55%
The Netherlands	210.99M	206.27M	205.91M	49.40M	-
The Netherlands Growth	2.29%	0.18%	316.85%	-	-
United Kingdom	169.49M	206.90M	186.82M	142.16M	161.71M
United Kingdom Growth	-18.08%	10.75%	31.42%	-12.09%	-24.56%
Rest of The World (ROW)	321.43M	248.45M	207.73M	114.05M	109.28M
Rest of The World (ROW) Growth	29.37%	19.60%	82.14%	4.37%	58.09%
Total	3.07B	2.77B	2.55B	2.07B	1.94B
Total Growth	10.98%	8.51%	23.30%	6.56%	6.54%

Source: S&P Global Market Intelligence.